Growing Funding Lucid Scientific has recently secured $7 million in Series A funding, indicating strong investor confidence and potential for expansion in product development, marketing, and sales outreach efforts.

Award-Winning Innovation The company's flagship RESIPHER product has received prestigious design awards, positioning it as a cutting-edge solution that can be promoted to research institutions seeking innovative laboratory instruments.

Recently Expanded Leadership With the addition of a new Board member from IAG Venture Partners, Lucid Scientific demonstrates strategic growth and openness to new industry partnerships, creating opportunities for collaborative sales efforts.

Market Positioning Operating in the biotech research industry with revenue between $10M and $25M, Lucid Scientific targets mid-sized research labs and institutions that could benefit from its real-time cell monitoring technology.

Product Focus Resipher’s unique real-time oxygen consumption monitoring in standard multi-well plates offers a compelling value proposition for research labs seeking improved cell culture management, presenting strong upsell opportunities for existing clients.